|
Can’t access the links? Add “lnks.gd” to the allowlist of your content blocking software. |
|
|
Effective for claims on or after March 1, 2024, the Health Care Authority, Apple Health Fee-For-Service (FFS) has increased the maximum allowable days’ supply for Mavyret (glecaprevir/pibrentasvir).
Pharmacies may dispense and submit claims for up to a 12-week (84 days) supply of Mavyret in a single fill.
|
|
|
To ensure patients receive the full course of treatment, Mavyret prescriptions should be written in a manner to allow the pharmacy to dispense the entire 8-week or 12-week course of treatment.
|
|
|
For additional questions, please email us at:
|
|
|
|